Promising results from an implemented treatment model for paediatric obesity.

behavioural treatment childhood obesity treatment implementation parental education personalised medicine

Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
08 2020
Historique:
received: 08 07 2019
revised: 29 11 2019
accepted: 02 01 2020
pubmed: 4 1 2020
medline: 8 5 2021
entrez: 4 1 2020
Statut: ppublish

Résumé

To investigate the implementation of a plan of action for treatment of childhood obesity, and the effect after 2 years of treatment. Children aged 6-12.9 years who started obesity treatment between 2008 and 2015 in a paediatric clinic in Stockholm County were included. The treatment model included staff education and support and group activities for parents and children separately followed by individual sessions to a multidisciplinary team. The main outcome was change in body mass index standard deviation score (BMI SDS), in comparison to a matched control group. In the intervention group, 1334 children (52% boys) with an average age of 9.3 years and BMI SDS of 2.7 and 3012 children in the control group were included. The intervention group decreased their BMI SDS more after two years compared with the control group, (-0.31 vs -0.23, P < .001). Younger age and higher BMI SDS at treatment initiation and families that completed the group sessions (all P < .001) had greater decreases in BMI SDS after 2 years. Sex did not affect the outcome. Even though the treatment in the control group was effective, the implementation of the action plan yielded a better treatment response compared with the control group.

Identifiants

pubmed: 31899803
doi: 10.1111/apa.15158
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1656-1664

Informations de copyright

© 2020 The Authors. Acta Paediatrica Published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.

Références

Hagman E, Danielsson P, Brandt L, Ekbom A, Marcus C. Association between impaired fasting glycaemia in pediatric obesity and type 2 diabetes in young adulthood. Nutr Diabetes. 2016;6(8):e227.
Hagman E, Danielsson P, Brandt L, Svensson V, Ekbom A, Marcus C. Childhood obesity, obesity treatment outcome, and achieved education: a prospective cohort study. J Adolesc Health. 2017;61(4):508-513.
Hagman E, Hecht L, Marko L, et al. Predictors of responses to clinic-based childhood obesity care. Pediatr Diabetes. 2018;19(8):1351-1356.
Danielsson P, Kowalski J, Ekblom O, Marcus C. Response of severely obese children and adolescents to behavioral treatment. Arch Pediatr Adolesc Med. 2012;166(12):1103-1108.
Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years. Cochrane Database Syst Rev. 2017;6:CD012651.
Oude Luttikhuis H, Baur L, Jansen H, et al. Interventions for treating obesity in children. Cochrane Database Syst Rev. 2009;1:CD001872.
Janicke DM, Steele RG, Gayes LA, et al. Systematic review and meta-analysis of comprehensive behavioral family lifestyle interventions addressing pediatric obesity. J Pediatr Psychol. 2014;39(8):809-825.
Danielsson P, Svensson V, Kowalski J, Nyberg G, Ekblom O, Marcus C. Importance of age for 3-year continuous behavioral obesity treatment success and dropout rate. Obes Facts. 2012;5(1):34-44.
Danielsson P, Bohlin A, Bendito A, Svensson A, Klaesson S. Five-year outpatient programme that provided children with continuous behavioural obesity treatment enjoyed high success rate. Acta Paediatr. 2016;105(10):1181-1190.
Findholt NE, Davis MM, Michael YL. Perceived barriers, resources, and training needs of rural primary care providers relevant to the management of childhood obesity. J Rural Health. 2013;29(suppl 1):s17-24.
Schalkwijk AAH, Nijpels G, Bot SDM, Elders PJM. Health care providers' perceived barriers to and need for the implementation of a national integrated health care standard on childhood obesity in the Netherlands - a mixed methods approach. BMC Health Serv Res. 2016;16:83.
Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7(4):284-294.
Ford AL, Hunt LP, Cooper A, Shield JP. What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health? Arch Dis Child. 2010;95(4):256-261.
Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis. 2009;207(1):174-180.
World Health Oganization G, Switzerland. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF Consultation. 2006.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62-S69.
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.
Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319-334.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 suppl 4th Report):555-576.
Ells LJ, Rees K, Brown T, et al. Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews. Int J Obes (Lond). 2018;42(11):1823-1833.
Golan M, Kaufman V, Shahar DR. Childhood obesity treatment: targeting parents exclusively v. parents and children. Br J Nutr. 2006;95(5):1008-1015.
Ek A, Lewis Chamberlain K, Sorjonen K, et al. A parent treatment program for preschoolers with obesity: a randomized controlled trial. Pediatrics. 2019;144(2):e20183457.
Ek A, Chamberlain KL, Ejderhamn J, et al. The more and less study: a randomized controlled trial testing different approaches to treat obesity in preschoolers. BMC Public Health. 2015;15:735.
Force USPST, Grossman DC, Bibbins-Domingo K, et al. Screening for obesity in children and adolescents: US preventive services task force recommendation statement. JAMA. 2017;317(23):2417-2426.
Forsell C, Gronowitz E, Larsson Y, Kjellberg BM, Friberg P, Marild S. Four-year outcome of randomly assigned lifestyle treatments in primary care of children with obesity. Acta Paediatr. 2019;108(4):718-724.
Hagman E, Reinehr T, Kowalski J, Ekbom A, Marcus C, Holl RW. Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents. Int J Obes (Lond). 2014;38(1):40-45.
Damanhoury S, Newton AS, Rashid M, Hartling L, Byrne JLS, Ball GDC. Defining metabolically healthy obesity in children: a scoping review. Obes Rev. 2018;19(11):1476-1491.

Auteurs

Emilia Hagman (E)

Division of Paediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Anna Bohlin (A)

Department of Women's and Children's Health, Södertälje Hospital, Sodertalje, Sweden.

Sven Klaesson (S)

Department of Women's and Children's Health, Södertälje Hospital, Sodertalje, Sweden.

Jan Ejderhamn (J)

Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

Pernilla Danielsson (P)

Division of Paediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH